FIELD: medicine.
SUBSTANCE: composition contains HIV fusion protein. Also, there is disclosed the application of such composition for manufacturing a drug for HIV immune response elicitation and a method for immune response elicitation with using thereof.
EFFECT: HIV immune response elicitation.
31 cl, 8 dwg
Authors
Dates
2010-12-27—Published
2004-10-25—Filed